Godavari Drugs Ltd. (GODAVARI) Drugs Share Price near 52-week high as stock trades at Rs 133.85

Godavari Drugs Share Price is Rs 133.85, up 3.64%, and trading near its 52-week high. The company’s market capitalisation is Rs 140.96 crore, keeping Godavari Drugs Share Price in focus for investors tracking Godavari Drugs Share Price Today and Godavari Drugs Stock News.

Godavari Drugs Share Price is trading at Rs 133.85, up Rs 4.70 or 3.64%, and the stock remains close to its 52-week high after moving between Rs 125.60 and Rs 137.00 during the latest session. Godavari Drugs Ltd. has a market capitalisation of Rs 140.96 crore, which places the move in a compact market-cap setting for today’s Godavari Drugs Share Price Today watchlist. According to latest Univest data, the event confirms a near one-year high setup, but it does not establish a company-specific catalyst.

Godavari Drugs Share Price Today: Price Action Analysis

For readers following Godavari Drugs Share Price, the key point is simple: the latest price action shows the stock holding near its yearly high while the broader Godavari Drugs Stock News flow remains limited to verified market data. The near 52-week peak keeps Godavari Drugs Share Price in search interest for Godavari Drugs Share Price Live, Godavari Drugs Latest News and Godavari Drugs Share Price Update queries.

At the same time, the latest Univest figures also show a valuation profile that is easy to compare with the Pharma sector and the Pharmaceuticals & Drugs industry. Godavari Drugs Share Price therefore matters not only for the day move, but also for how its P/E, P/B, ROE, ROCE, EPS and book value sit against the sector benchmark and peer set. Investors watching Godavari Drugs Share Price Today can use that mix of price action and fundamentals to understand why the stock is appearing in 52 Week High Stocks searches.

Metric	Value
Current Price	Rs 133.85
Previous Close	Rs 129.15
Today's Move	+Rs 4.7 (+3.64%)
Open	Rs 125.6
High	Rs 137
Low	Rs 125.6
Market Capitalisation	Rs 140.96 crore

Godavari Drugs Ltd. (GODAVARI) traded at Rs 133.85 versus the previous close of Rs 129.15, a rise of 3.64%. The stock opened at Rs 125.6, reached a high of Rs 137 and touched a low of Rs 125.6.

Godavari Drugs Share Price Today shows a clear intraday advance from the previous close of Rs 129.15 to Rs 133.85. The stock opened at Rs 125.60, touched a low of Rs 125.60 and reached a high of Rs 137.00, keeping Godavari Drugs Share Price within reach of its 52-week high throughout the move. The day change of Rs 4.70 and 3.64% is the central price point for Godavari Drugs Share Price Today.

The near-peak placement matters because Godavari Drugs Share Price is now being discussed as a 52 Week High stock rather than a routine daily mover. The move from the previous close to the current level can be read directly from price data, without attaching an unverified reason. For Godavari Drugs Stock News, the latest Univest figures confirm the price event and the distance to the yearly high, while leaving the cause unassigned.

Because the stock is still trading within the day’s range and near its 52-week high, Godavari Drugs Share Price remains a live market update rather than an end-of-day snapshot. That makes Godavari Drugs Share Price Today relevant for Indian Stock Market searches, Share Market Today scans and Stocks in News screens.

Godavari Drugs Ltd. (GODAVARI) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 140.96 crore
P/E Ratio	33.92x
P/B Ratio	1.79x
ROE	10.64%
ROCE	10.13%
EPS	Rs 3.81
Book Value Per Share	Rs 72.07
Dividend Yield	0%

Godavari Drugs Ltd. (GODAVARI) fundamental metrics show P/E 33.92x, P/B 1.79x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.

Godavari Drugs Ltd. has a market capitalisation of Rs 140.96 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 33.92x, P/B at 1.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.02x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	33.92x
Benchmark Median P/E	27.02x
Benchmark Average P/E	40.02x
Benchmark P/E Range	0x to 678.22x
Company P/B Ratio	1.79x
Benchmark Median P/B	2.81x
Company ROE	10.64%
Benchmark Median ROE	11.61%
Company ROCE	10.13%
Benchmark Median ROCE	13.46%
Company Market Capitalisation	Rs 140.96 crore
Benchmark Median Market Cap	Rs 852.55 crore

Godavari Drugs Ltd. (GODAVARI) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 33.92x, which is above the benchmark median of 27.02x, a difference of +25.54%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Godavari Drugs Ltd. (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 11.61%, a difference of -8.35%. Godavari Drugs Ltd. (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.46%, a difference of -24.74%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Gujarat Inject (Kerala) Ltd.	GUJINJEC	138.73	46.35	10.6	3.44	2.54
Auro Laboratories Ltd.	AUROLAB	144.03	30.76	3.04	7.91	9.17
Quest Laboratories Ltd.	QUESTLAB	145.85	9.71	1.51	24.56	26.87
Panchsheel Organics Ltd.	PANCHSHEEL	134.88	13.1	0.94	10.66	13.65
Par Drugs And Chemicals Ltd.	PAR	149.46	10.31	1.28	14.47	19.51

Godavari Drugs Ltd. (GODAVARI) has a P/E ratio of 33.92x compared with the displayed peer median of 13.1x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.64% compares with a peer median of 10.66% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 13.65%, providing a capital-efficiency comparison. Godavari Drugs Ltd. (GODAVARI) has a market capitalisation of Rs 140.96 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Godavari Drugs

• Godavari Drugs Share Price is Rs 133.85, up 3.64% from the previous close of Rs 129.15.
• The stock is trading near its 52-week high after touching Rs 137.00 in the latest session.
• Godavari Drugs Market Cap stands at Rs 140.96 crore.
• Godavari Drugs Share Price has a P/E ratio of 33.92 and a P/B ratio of 1.79.
• ROE is 10.64% and ROCE is 10.13%, both below the industry medians in the same-industry set.

About Godavari Drugs

Godavari Drugs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Godavari Drugs Share Price therefore belongs to a business classified within the same industry group used in the sector benchmark and peer comparison above. For readers following Godavari Drugs Share Price Today, that classification is the most reliable company-level context available in the latest Univest data.

Frequently Asked Questions

What is Godavari Drugs Share Price today?

Ans. Godavari Drugs Share Price is Rs 133.85, up 3.64% from the previous close of Rs 129.15. The stock also traded between Rs 125.60 and Rs 137.00 in the latest session.

Why is Godavari Drugs Share Price near a 52-week high?

Ans. Godavari Drugs Share Price is trading close to its yearly high because the latest price is near Rs 137.00. The data confirms the near-peak event, but it does not establish a company-specific trigger.

What is Godavari Drugs market capitalisation?

Ans. Godavari Drugs Market Cap is Rs 140.96 crore. That places the company well below the same-industry median market capitalisation of Rs 852.55 crore in the Pharmaceuticals & Drugs benchmark set.

How does Godavari Drugs Share Price compare on valuation?

Ans. Godavari Drugs Share Price has a P/E of 33.92 and a P/B of 1.79. The P/E is above the same-industry median, while the P/B is below the same-industry median of 2.81.

What do ROE and ROCE show for Godavari Drugs?

Ans. Godavari Drugs reports ROE of 10.64% and ROCE of 10.13%. Both are below the same-industry medians, which helps frame Godavari Drugs Fundamental Analysis alongside valuation and EPS. The relevant peer median ROE is 11.61%.

What is Godavari Drugs EPS and book value?

Ans. Godavari Drugs EPS is Rs 3.81 and book value per share is Rs 72.07. These figures add basic earnings and accounting-value context to Godavari Drugs Share Price and Godavari Drugs Stock Analysis.

Does Godavari Drugs pay a dividend?

Ans. Godavari Drugs shows a dividend yield of 0.00%. That means the current dataset does not indicate a cash dividend yield, so investors are left to focus on price, valuation and profitability metrics.

Which sector and industry does Godavari Drugs belong to?

Ans. Godavari Drugs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is central to Godavari Drugs Share Price comparison against peers and the same-industry benchmark.

Track Godavari Drugs Share Price on Univest

Use Godavari Drugs Ltd. (GODAVARI) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Godavari Drugs Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels, sector context and related stock insights. Godavari Drugs Share Price Today, Godavari Drugs Stock News and Godavari Drugs Share News can all be followed from the same stock page.

Image ALT: Godavari Drugs Share Price near 52-week high with valuation and sector context on Univest